124 related articles for article (PubMed ID: 17702729)
1. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population.
Rashidi A; Ghanbarian A; Azizi F
Clin J Am Soc Nephrol; 2007 Sep; 2(5):976-83. PubMed ID: 17702729
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
Kurella M; Lo JC; Chertow GM
J Am Soc Nephrol; 2005 Jul; 16(7):2134-40. PubMed ID: 15901764
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
Lucove J; Vupputuri S; Heiss G; North K; Russell M
Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study.
Ninomiya T; Kiyohara Y; Kubo M; Yonemoto K; Tanizaki Y; Doi Y; Hirakata H; Iida M
Am J Kidney Dis; 2006 Sep; 48(3):383-91. PubMed ID: 16931211
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort.
Sun F; Tao Q; Zhan S
Nephrology (Carlton); 2010 Feb; 15(1):84-92. PubMed ID: 20377775
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey.
Yu M; Ryu DR; Kim SJ; Choi KB; Kang DH
Nephrol Dial Transplant; 2010 Feb; 25(2):469-77. PubMed ID: 19762608
[TBL] [Abstract][Full Text] [Related]
9. Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study.
Haysom L; Williams R; Hodson E; Lopez-Vargas P; Roy LP; Lyle D; Craig JC
Am J Kidney Dis; 2009 Feb; 53(2):229-37. PubMed ID: 18930569
[TBL] [Abstract][Full Text] [Related]
10. Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.
Yoon YS; Park HS; Yun KE; Kim SB
Metabolism; 2009 Dec; 58(12):1737-42. PubMed ID: 19615700
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
[TBL] [Abstract][Full Text] [Related]
12. Frequency of risk factors for foot ulceration in individuals with chronic kidney disease.
Freeman A; May K; Frescos N; Wraight PR
Intern Med J; 2008 May; 38(5):314-20. PubMed ID: 18005131
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification.
Johnson DW; Armstrong K; Campbell SB; Mudge DW; Hawley CM; Coombes JS; Prins JB; Isbel NM
Nephrology (Carlton); 2007 Aug; 12(4):391-8. PubMed ID: 17635756
[TBL] [Abstract][Full Text] [Related]
15. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
[TBL] [Abstract][Full Text] [Related]
16. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
[TBL] [Abstract][Full Text] [Related]
17. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
18. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
20. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
